-
Dosimetric predictors of acute and late gastrointestinal toxicities in stereotactic online adaptive magnetic resonance-guided radiotherapy (SMART) for locally advanced pancreatic adenocarcinoma. Radiother Oncol. 2024 Aug 11; 200:110473.
D'Souza A, Stowe HB, Green OL, Schiff J, Hugo GD, Ginn J, Maraghechi B, Kang KH, Kim H, Badiyan SN, Samson P, Robinson CG, Price A, Henke LE. PMID: 39137832.
View in:
PubMed Mentions: Fields:
Translation:
HumansPHPublic Health
-
Cone-Beam Computed Tomography (CBCT)-Guided Adaptive Boost Radiotherapy for a Patient With Locally Advanced Cervical Cancer Ineligible for Brachytherapy. Cureus. 2024 Aug; 16(8):e66218.
Silberstein AE, Schiff JP, Beckert R, Zhao X, Laugeman E, Markovina S, Contreras JA. PMID: 39233928; PMCID: PMC11374352.
View in:
PubMed Mentions:
-
Feasibility of simulation free abdominal stereotactic adaptive radiotherapy using an expedited pre-plan workflow. Phys Imaging Radiat Oncol. 2024 Jul; 31:100611.
Price AT, Schiff JP, Silberstein A, Beckert R, Zhao T, Hugo GD, Samson PP, Laugeman E, Henke LE. PMID: 39253730; PMCID: PMC11382001.
View in:
PubMed Mentions:
-
The First Reported Case of Treating the Ultra-Central Thorax With Cone Beam Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR). Cureus. 2024 Jun; 16(6):e62906.
Zhao S, Beckert R, Zhao X, Laugeman E, Robinson CG, Vlacich G, Samson PP, Schiff JP. PMID: 39040774; PMCID: PMC11262774.
View in:
PubMed Mentions:
1
-
The impact of an Advanced Practice Radiation Therapist contouring for a CBCT-based adaptive radiotherapy program. Tech Innov Patient Support Radiat Oncol. 2024 Jun; 30:100242.
Beckert R, Schiff JP, Morris E, Samson P, Kim H, Laugeman E. PMID: 38495830; PMCID: PMC10940769.
View in:
PubMed Mentions:
1
-
Feasibility of surface-guidance combined with CBCT for intra-fractional breath-hold motion management during Ethos RT. J Appl Clin Med Phys. 2024 Apr; 25(4):e14242.
Kim T, Laugeman E, Kiser K, Schiff J, Marasini S, Price A, Gach HM, Knutson N, Samson P, Robinson C, Hatscher C, Henke L. PMID: 38178622; PMCID: PMC11005966.
View in:
PubMed Mentions:
3 Fields:
Translation:
HumansCTClinical Trials
-
The Use of MR-Guided Radiation Therapy for Liver Cancer. Semin Radiat Oncol. 2024 01; 34(1):36-44.
Prime S, Schiff JP, Hosni A, Stanescu T, Dawson LA, Henke LE. PMID: 38105091.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
A feasibility trial of skin surface motion-gated stereotactic body radiotherapy for treatment of upper abdominal or lower thoracic targets using a novel O-ring gantry. Clin Transl Radiat Oncol. 2024 Jan; 44:100692.
Kiser K, Schiff J, Laugeman E, Kim T, Green O, Hatscher C, Kim H, Badiyan S, Spraker M, Samson P, Robinson C, Price A, Henke L. PMID: 38021090; PMCID: PMC10652138.
View in:
PubMed Mentions:
4
-
Initial clinical experience building a dual CT- and MR-guided adaptive radiotherapy program. Clin Transl Radiat Oncol. 2023 Sep; 42:100661.
Price AT, Schiff JP, Laugeman E, Maraghechi B, Schmidt M, Zhu T, Reynoso F, Hao Y, Kim T, Morris E, Zhao X, Hugo GD, Vlacich G, DeSelm CJ, Samson PP, Baumann BC, Badiyan SN, Robinson CG, Kim H, Henke LE. PMID: 37529627; PMCID: PMC10388162.
View in:
PubMed Mentions:
1
-
Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience. Clin Transl Radiat Oncol. 2023 Jul; 41:100627.
Chin RI, Schiff JP, Bommireddy A, Kang KH, Andruska N, Price AT, Green OL, Huang Y, Korenblat K, Parikh PJ, Olsen J, Samson PP, Henke LE, Kim H, Badiyan SN. PMID: 37441543; PMCID: PMC10334127.
View in:
PubMed Mentions:
2
-
Prospective In Silico Evaluation of Cone-Beam Computed Tomography-Guided StereoTactic Adaptive Radiation Therapy (CT-STAR) for the Ablative Treatment of Ultracentral Thoracic Disease. Adv Radiat Oncol. 2023 Nov-Dec; 8(6):101226.
Schiff JP, Laugeman E, Stowe HB, Zhao X, Hilliard J, Hawk E, Watkins J, Hatscher C, Badiyan SN, Samson PP, Hugo GD, Robinson CG, Price AT, Henke LE. PMID: 37206996; PMCID: PMC10188549.
View in:
PubMed Mentions:
4
-
Knowledge-based adaptive planning quality assurance using dosimetric indicators for stereotactic adaptive radiotherapy for pancreatic cancer. Radiother Oncol. 2023 05; 182:109603.
Forghani F, Ginn JS, Schiff JP, Zhu T, Marut L, Laugeman E, Maraghechi B, Badiyan SN, Samson PP, Kim H, Robinson CG, Hugo GD, Henke LE, Price AT. PMID: 36889595.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer. Dis Colon Rectum. 2023 07 01; 66(7):973-982.
Chin RI, Schiff JP, Shetty AS, Pedersen KS, Aranha O, Huang Y, Hunt SR, Glasgow SC, Tan BR, Wise PE, Silviera ML, Smith RK, Suresh R, Byrnes K, Samson PP, Badiyan SN, Henke LE, Mutch MG, Kim H. PMID: 36876988.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Ablative radiotherapy for colorectal liver metastases and intrahepatic cholangiocarcinoma. Surgery. 2023 07; 174(1):108-112.
Schiff JP, D'Souza A, Henke LE. PMID: 36870808.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
First treatments for Lattice stereotactic body radiation therapy using magnetic resonance image guided radiation therapy. Clin Transl Radiat Oncol. 2023 Mar; 39:100577.
Price AT, Schiff JP, Zhu T, Mazur T, Kavanaugh JA, Maraghechi B, Green O, Kim H, Spraker MB, Henke LE. PMID: 36718251; PMCID: PMC9883196.
View in:
PubMed Mentions:
1
-
A pilot study of same-day MRI-only simulation and treatment with MR-guided adaptive palliative radiotherapy (MAP-RT). Clin Transl Radiat Oncol. 2023 Mar; 39:100561.
Schiff JP, Maraghechi B, Chin RI, Price A, Laugeman E, Rudra S, Hatscher C, Spraker MB, Badiyan SN, Henke LE, Green O, Kim H. PMID: 36594078; PMCID: PMC9803918.
View in:
PubMed Mentions:
5
-
Simulation-Free Radiation Therapy: An Emerging Form of Treatment Planning to Expedite Plan Generation for Patients Receiving Palliative Radiation Therapy. Adv Radiat Oncol. 2023 Jan-Feb; 8(1):101091.
Schiff JP, Zhao T, Huang Y, Sun B, Hugo GD, Spraker MB, Abraham CD. PMID: 36304132; PMCID: PMC9594122.
View in:
PubMed Mentions:
9
-
An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's Oncology Group Study ACNS0331). Adv Radiat Oncol. 2023 Jan-Feb; 8(1):101083.
Schiff JP, Lee Y, Wang Y, Perkins SM, Kessel SK, Fitzgerald TJ, Larrier NA, Michalski JM. PMID: 36483060; PMCID: PMC9723303.
View in:
PubMed Mentions:
1
-
The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR). Radiat Oncol. 2022 Sep 13; 17(1):157.
Kim M, Schiff JP, Price A, Laugeman E, Samson PP, Kim H, Badiyan SN, Henke LE. PMID: 36100866; PMCID: PMC9472353.
View in:
PubMed Mentions:
11 Fields:
Translation:
Humans
-
Simulated computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR) for the treatment of locally advanced pancreatic cancer. Radiother Oncol. 2022 10; 175:144-151.
Schiff JP, Price AT, Stowe HB, Laugeman E, Chin RI, Hatscher C, Pryser E, Cai B, Hugo GD, Kim H, Badiyan SN, Robinson CG, Henke LE. PMID: 36063981.
View in:
PubMed Mentions:
18 Fields:
Translation:
HumansCTClinical Trials
-
In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiation Therapy (CT-STAR) for the Treatment of Abdominal Oligometastases. Int J Radiat Oncol Biol Phys. 2022 12 01; 114(5):1022-1031.
Schiff JP, Stowe HB, Price A, Laugeman E, Hatscher C, Hugo GD, Badiyan SN, Kim H, Robinson CG, Henke LE. PMID: 35768023.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansCTClinical Trials
-
Overall survival in patients with FIGO stage IVA cervical cancer. Gynecol Oncol. 2022 08; 166(2):292-299.
Schiff JP, Mintz R, Cohen AC, Huang Y, Thaker P, Massad LS, Powell M, Mutch D, Schwarz JK, Markovina ST, Grigsby PW. PMID: 35691754.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Oligometastatic Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Chemotherapy With Nonoperative Intent of the Primary for Locoregional Complete Responders. Pract Radiat Oncol. 2022 Sep-Oct; 12(5):e406-e414.
Schiff JP, Chin RI, Roy A, Mahapatra L, Stowe HB, Andruska N, Huang Y, Mutch M, Fields RC, Hawkins WG, Doyle M, Chapman W, Tan B, Henke LE, Badiyan SN, DeSelm C, Samson PP, Pedersen K, Kim H. PMID: 35526826.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
The impact of tumor size and histology on local control when utilizing high-dose-rate interstitial brachytherapy for gynecologic malignancies. Gynecol Oncol. 2022 06; 165(3):486-492.
Schiff JP, Mahmood M, Huang Y, Powell MA, Mutch D, Dyk PT, Lin AJ, Schwarz JK, Markovina ST, Grigsby PW. PMID: 35370010.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
A Rational Approach to Unilateral Neck RT for Head and Neck Cancers in the Era of Immunotherapy. Cancers (Basel). 2021 Oct 20; 13(21).
Chin RI, Schiff JP, Brenneman RJ, Gay HA, Thorstad WL, Lin AJ. PMID: 34771432; PMCID: PMC8582444.
View in:
PubMed Mentions:
1
-
Tumor Lysis Syndrome in a Patient With Metastatic Endometrial Cancer Treated With Lattice Stereotactic Body Radiation Therapy. Adv Radiat Oncol. 2022 Jan-Feb; 7(1):100797.
Schiff JP, Spraker MB, Duriseti S, Shaikh S, Murad HF, Mutch DG, Robinson CG, Kavanaugh J, Lin AJ. PMID: 34761139; PMCID: PMC8567179.
View in:
PubMed Mentions:
6
-
Technical Challenges of Heart Avoidance for Synchronous Breast and Lung Cancers in a Postmenopausal Female: A Planning Case Report From a Safety-Net Hospital. Adv Radiat Oncol. 2020 Sep-Oct; 5(5):1076-1082.
Marques C, Schiff J, Momin F, McAllister N, Jennelle RL, Bian SX, Schechter NR, Yoo SK. PMID: 33083670; PMCID: PMC7557127.
View in:
PubMed Mentions:
-
Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer. BMC Cancer. 2019 May 31; 19(1):524.
Schiff JP, Cotogno P, Feibus A, Steinwald P, Ledet E, Lewis B, Sartor O. PMID: 31151428; PMCID: PMC6544996.
View in:
PubMed Mentions:
6 Fields:
Translation:
HumansCells
-
First Reported Case of Pediatric Radiation Treatment With Magnetic Resonance Image Guided Radiation Therapy. Adv Radiat Oncol. 2019 Apr-Jun; 4(2):233-236.
Henke LE, Green OL, Schiff J, Rodriguez VL, Mutic S, Michalski J, Perkins SM. PMID: 31011667; PMCID: PMC6460231.
View in:
PubMed Mentions:
9
-
Prostate-specific Antigen Response and Eradication of Androgen Receptor Amplification with High-dose Testosterone in Prostate Cancer. Eur Urol. 2017 06; 71(6):997-998.
Schiff JP, Lewis BE, Ledet EM, Sartor O. PMID: 28040353.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans